MAXYGEN INC
8-K/A, EX-23.1, 2000-10-24
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MAXYGEN INC, 8-K/A, 2000-10-24
Next: PRUDENTIAL TAX MANAGED FUNDS, AW, 2000-10-24



<PAGE>

                                                                    Exhibit 23.1



                         CONSENT OF INDEPENDENT AUDITORS



We have issued our reports dated February 23, 2000 (except for Notes 11 and 12
as to which the date is October 23, 2000), accompanying the financial statements
of ProFound Pharma A/S contained in this Form 8-K/A. We hereby consent to the
incorporation by reference of said reports in the Registration Statements of
Maxygen, Inc. on Forms S-8 (File No. 333-93423 effective December 22, 1999, File
No. 333-38078 effective May 30, 2000, and File No. 333-44794 effective August
30, 2000).


/s/ Grant Thornton Denmark Ltd.


Copenhagen, Denmark
October 23, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission